Question: Innovate in India (i3) Programme has been started by…
(a) Department of Heavy Industry (DHI)
(b) Department of Public Enterprises
(c) Department of Bio-Technology (DBT)
(d) Department of Science and Technology (DST)
Ans: (c)
- In a bid to create a globally competitive biopharmaceutical industry that addresses the country’s major concerns around barriers to affordable healthcare, Union Minister for Science &Technology, Dr. Harsh Vardhan launched ‘ Innovate in India (i3)’ program on June 30, 2017 in New Delhi.
- This program has been started by the Department of Biotechnology (DBT), Ministry of Science & Technology and is a first- of-its-kind mission that brings together industry and academia to promote entrepreneurship and indigenous manufacturing in the biopharmaceutical sector.
- This 250 million USD flagship program of the GOI in collaboration with World Bank, will be implemented by Biotechnology Industry Research Assistance Council (BIRAC), a Public Sector Enterprise, set up by DBT.
- This programme is focussed on targeted measures to develop platform technologies for product validation, link disparate institutions to strengthen clinical trial networks, promote partial de-risking for novel products, and build capacities in emerging areas such as translational bioinformatics, bioethics etc.
Reference:
http://pib.nic.in/newsite/PrintRelease.aspx?relid=167052